Skip to main content
. 2014 Feb 11;63(5):419–435. doi: 10.1007/s00262-014-1523-1

Fig. 2.

Fig. 2

Number of IL-12-based clinical trials in the field of tumor immunotherapy that have been started since 1996 and have been registered in ClinicalTrials.gov database (http://www.clinicaltrials.gov). The histogram comprises studies in which IL-12 was used alone or in combination, either as a main therapeutic or administered in an adjuvant setting including gene therapy